Human parainfluenza virus type 3 (HPIV-3) is a respiratory paramyxovirus that infects lung epithelial cells to cause high morbidity among infants and children. To date, no effective vaccine or anti-viral therapy exists for HPIV-3 and therefore, elucidation of innate immune anti-viral response induced by this virus in infected epithelial cells hold significant potential for development of effective anti-viral therapies. Interferon-a (IFN) is a critical anti-viral cytokine that activates Janus kinases/signal transducers and activators of transcription (JAK/STAT) pathway to induce anti-viral proteins. Therefore, anti-viral action of IFN constitutes an important arm of host-derived innate immunity. Recently we reported (Basu et al. J. Gen. Virol. 87:2653-2662, 2006) the ability of IFN to activate soluble secreted anti-viral proteins via JAK/STAT independent fashion. In an attempt to characterize the JAK/STAT independent pathway, our preliminary studies have revealed that IFN induces human beta defensin-3 (HBD3), a soluble secreted anti-microbial protein in human lung epithelial cells and purified HBD3 inhibited HPIV-3 infection in these cells. Interestingly, HBD3 induction by IFN was dependent on extracellular signal-regulated kinase [ERK, a component of mitogen-activated protein kinase (MAPK) pathway] activation and was JAK/STAT independent. Further characterization of HBD3 gene revealed presence of two consensus AP-1 binding sites. Based on these results and the ability of IFN to activate AP-1 transcription factors, we hypothesize that HBD3 is a novel IFN induced anti-viral protein which is produced independent of JAK/STAT pathway probably via activation of ERK/AP1 signaling cascade. We plan to characterize this novel JAK/STAT independent pathway in details by the following specific aims: 1. Study the role of human beta defensin-3 (HBD3) as an IFN induced anti-viral protein in human lung epithelial cells. Based on our preliminary results, we plan to establish HBD3 as an extracellular IFN induced anti-viral protein. The contribution of HBD3 during anti-viral action of IFN will be studied using HBD3 over- expressing cells and cells suppressed for endogenous expression of HBD3 (achieved via siRNA technology). 2. Characterize the mechanism of JAK/STAT independent induction of HBD3 by IFN: role of ERK/AP- 1 pathway. The importance of ERK/AP-1 pathway in HBD3 gene expression will be analyzed by utilizing a) dominant-negative and constitutively active MAPKs/AP-1, b) siRNA against MAPKs/AP-1. We will also emphasis on the contribution of IFN induced ERK/AP-1 pathway during JAK/STAT independent anti-viral signaling by studying mechanism of trans-activation of anti-viral factors like HBD3. Relevance: The current application aims to study the anti-viral function of HBD3 against highly pathogenic human respiratory virus, HPIV-3. In addition, it aims at characterization of lesser-known JAK/STAT independent anti-viral pathway induced by IFN. These studies are important for development of novel anti- viral therapies against HPIV-3 and potentially for other respiratory paramyxoviruses. Human parainfluenza virus type 3 (HPIV-3) is a highly pathogenic respiratory virus that infects infants and children. Currently, no vaccine or anti-viral therapy exists to counteract HPIV-3 interaction. Our proposed research is focused on elucidating novel anti-viral innate immune response mechanism against HPIV-3. The knowledge derived from the proposed studies will be helpful in development of efficient anti-viral therapeutics against HPIV-3 infection. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AI069062-01A2
Application #
7313427
Study Section
Special Emphasis Panel (ZRG1-IDM-G (91))
Program Officer
Palker, Thomas J
Project Start
2007-09-19
Project End
2009-08-31
Budget Start
2007-09-19
Budget End
2008-08-31
Support Year
1
Fiscal Year
2007
Total Cost
$180,200
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Microbiology/Immun/Virology
Type
Other Domestic Higher Education
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Echchgadda, Ibtissam; Chang, Te-Hung; Sabbah, Ahmed et al. (2011) Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense. BMC Cancer 11:43
Echchgadda, I; Kota, S; DeLa Cruz, I et al. (2009) Anticancer oncolytic activity of respiratory syncytial virus. Cancer Gene Ther 16:923-35
Sabbah, Ahmed; Chang, Te Hung; Harnack, Rosalinda et al. (2009) Activation of innate immune antiviral responses by Nod2. Nat Immunol 10:1073-80
Sabbah, Ahmed; Bose, Santanu (2009) Retinoic acid inducible gene I activates innate antiviral response against human parainfluenza virus type 3. Virol J 6:200
Kota, Srikanth; Sabbah, Ahmed; Chang, Te Hung et al. (2008) Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappaB-mediated innate antiviral response against human respiratory syncytial virus. J Biol Chem 283:22417-29